|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Eidos Therapeutics, Inc. (EIDX) |
|
|
$122.21 0.00 (0.00%) as of 4:30 Mon 1/25
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
38,660,000 |
| Market
Cap: |
4.72(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$122.21 - $122.21 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fox Jonathan C |
See Remarks |
• – – |
2021-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(380,467) |
0 |
|
- |
|
| Sinha Uma |
Chief Scientific Officer |
• – – |
2021-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(303,525) |
0 |
|
- |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2021-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,699) |
0 |
|
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2021-01-26 |
4 |
B |
$0.00 |
$0 |
D/D |
14,428,836 |
1,000 |
2.37 |
- |
|
| Sinha Uma |
Chief Scientific Officer |
• • – |
2021-01-13 |
4 |
AS |
$121.11 |
$1,243,179 |
D/D |
(10,000) |
306,525 |
|
1% |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2021-01-12 |
4 |
S |
$125.45 |
$219,152 |
D/D |
(1,747) |
0 |
|
3% |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2021-01-12 |
4 |
OE |
$7.24 |
$12,648 |
D/D |
1,747 |
1,747 |
|
- |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2021-01-11 |
4 |
S |
$125.61 |
$188,408 |
D/D |
(1,500) |
0 |
|
3% |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2021-01-11 |
4 |
OE |
$7.24 |
$10,860 |
D/D |
1,500 |
1,500 |
|
- |
|
| Fox Jonathan C |
See Remarks |
• – – |
2020-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
380,467 |
|
- |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2020-12-15 |
4 |
S |
$110.29 |
$2,938,796 |
D/D |
(26,294) |
50,621 |
|
-9% |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2020-12-15 |
4 |
OE |
$13.20 |
$363,995 |
D/D |
26,294 |
76,915 |
|
- |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2020-11-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
50,621 |
|
- |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2020-11-11 |
4 |
S |
$73.56 |
$999,227 |
D/D |
(13,410) |
52,121 |
|
-63% |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2020-11-09 |
4 |
S |
$74.93 |
$121,609 |
D/D |
(1,623) |
0 |
|
-65% |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2020-11-09 |
4 |
OE |
$7.24 |
$11,751 |
D/D |
1,623 |
1,623 |
|
- |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2020-11-02 |
4 |
AS |
$70.44 |
$883,954 |
D/D |
(12,500) |
65,531 |
|
71% |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2020-11-02 |
4 |
OE |
$13.20 |
$108,500 |
D/D |
7,500 |
78,031 |
|
- |
|
| Sinha Uma |
Chief Scientific Officer |
• • – |
2020-10-29 |
4 |
AS |
$71.90 |
$362,099 |
D/D |
(5,000) |
321,525 |
|
69% |
|
| Sinha Uma |
Chief Scientific Officer |
• – – |
2020-10-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
303,525 |
|
- |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2020-10-08 |
4 |
S |
$74.85 |
$389,151 |
D/D |
(5,199) |
0 |
|
-67% |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2020-10-08 |
4 |
OE |
$7.24 |
$37,641 |
D/D |
5,199 |
5,199 |
|
- |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2020-10-07 |
4 |
S |
$75.08 |
$408,748 |
D/D |
(5,444) |
0 |
|
-63% |
|
| Valle Franco |
Senior Vice President, Finance |
• – – |
2020-10-07 |
4 |
OE |
$7.24 |
$36,200 |
D/D |
5,000 |
5,444 |
|
- |
|
| Sinha Uma |
Chief Scientific Officer |
• • – |
2020-10-01 |
4 |
AS |
$52.35 |
$252,923 |
D/D |
(4,831) |
326,525 |
|
135% |
|
141 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
